Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chata Biosystems is a specialized manufacturer of custom chemical solutions, reagents, and mobile phases for the pharmaceutical, biotechnology, and analytical testing industries. Founded in 1997 and headquartered in Fort Collins, Colorado, the company provides high-quality, ready-to-use solutions designed to streamline laboratory workflows and ensure regulatory compliance. Their product portfolio includes pH buffers, dissolution media, and HPLC/LC-MS mobile phases, often delivered in proprietary packaging systems like CHEM-FILLED. In 2021, Chata Biosystems was acquired by Actylis (formerly Aceto), expanding its reach within the global life sciences supply chain. The company is recognized for its ability to provide precise, outsourced chemical blending that reduces internal lab preparation time and improves consistency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chata Biosystems.